MyFinsight
Home
Blog
About
Cash and cash
equivalents
$171,414K
(38.43%↑ Y/Y)
Prepaid expenses and
other current assets
$55,142K
(-18.76%↓ Y/Y)
Accounts receivable, net
$44,392K
(66.61%↑ Y/Y)
Inventories, net
$33,431K
(39.63%↑ Y/Y)
Marketable securities -
available-for-sale debt securities
$30,216K
(-90.86%↓ Y/Y)
Restricted cash
$1,496K
(-0.73%↓ Y/Y)
Total current assets
$336,091K
(-41.47%↓ Y/Y)
Operating lease
right-of-use assets, net
$74,111K
(26.43%↑ Y/Y)
Property and equipment,
net
$60,523K
(-8.94%↓ Y/Y)
Intangible assets, net
$18,532K
(43.29%↑ Y/Y)
Deferred tax asset
$2,788K
(16.07%↑ Y/Y)
Long-term deposits
$1,016K
(-3.42%↓ Y/Y)
Prepaid expenses and
other non-current...
$165K
(-96.86%↓ Y/Y)
Total assets
$493,226K
(-31.59%↓ Y/Y)
Total liabilities and
shareholders equity
$493,226K
(-31.59%↓ Y/Y)
Total liabilities
$418,387K
(11.71%↑ Y/Y)
Total shareholders
equity
$74,839K
(-78.40%↓ Y/Y)
Accumulated deficit
-$1,497,461K
(-23.01%↓ Y/Y)
Accumulated other
comprehensive loss
-$6,101K
(-807.77%↓ Y/Y)
Liabilities related to
future royalties and...
$271,400K
(10.94%↑ Y/Y)
Operating lease
liabilities, non-current
$77,723K
(26.88%↑ Y/Y)
Total current
liabilities
$68,790K
(0.94%↑ Y/Y)
Other long-term
payables
$474K
(-0.63%↓ Y/Y)
Additional paid-in capital
$1,578,271K
(0.99%↑ Y/Y)
Ordinary and deferred
shares, value-Deferred...
$118K
(0.00%↑ Y/Y)
Ordinary and deferred
shares, value-Ordinary...
$12K
(0.00%↑ Y/Y)
Accrued expenses and
other liabilities
$48,735K
(-5.12%↓ Y/Y)
Liabilities related to
future royalties and...
$12,900K
(115.00%↑ Y/Y)
Operating lease
liabilities, current
$5,789K
(76.66%↑ Y/Y)
Accounts payable
$1,366K
(-74.74%↓ Y/Y)
Compensation and benefits
$19,663K
Rebates, chargebacks and
returns
$9,193K
Research and development
costs
$6,887K
Professional fees
$6,324K
Manufacturing accruals
$4,204K
Other liabilities
$2,464K
Back
Back
Balance Sheet
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)
source: myfinsight.com